Affiliation:
1. Federal Research Center of Fundamental and Translational Medicine, Siberian Branch of
Russian Academy of Sciences
Abstract
Objective: isolation of coronavirus SARS-CoV-2 from clinical sample of patient with COVID-19 in Novosibirsk; obtaining a purified and inactivated viral antigen and study of its antigenic properties. Materials and methods: virus isolation was carried out in Vero cell culture from nasopharyngeal swab positive on SARS-CoV-2 RNA. The efficiency of SARSCoV-2 replication in cell culture was assessed on the appearance of cytopathic effect (CPE) and the presence of viral RNA in cultural medium with reverse transcription – polymerase chain reaction (RT-PCR). Purification, concentration and inactivation of the viral preparation were carried out according to standard methods. The purity of the purified preparation and the profile of viral proteins were determined by electrophoresis in 10% polyacrylamide gel (PAG) with the addition of sodium dodecyl sulfate (SDS). The presence and specificity of viral proteins were detected using COVID-19 convalescent’s sera with enzyme-linked immunosorbent assay (ELISA) and immunoblotting. Results: SARS-CoV-2/human/ RUS/Nsk-FRCFTM-1/2020 isolate was obtained after passage on Vero cells from a virus-containing clinical sample. A purified, concentrated, inactivated, whole-virion antigen was obtained. It contains three structural proteins: glycoprotein S (approximately 200 kDa), nucleoprotein N (48 kDa), and matrix protein M (20-25 kDa). All viral proteins were detected with serum antibodies of COVID-19 convalescents. Conclusion: SARS-CoV-2 coronavirus can be isolated in Vero cell culture. The antigenic specificity of the three structural viral proteins (S, N, and M) is preserved in the purified inactivated viral preparation. The inactivated whole-virion antigen of SARS-CoV-2/human/RUS/Nsk-FRCFTM-1/2020 isolate can be used to study the antigenic immunomodulating properties of viral proteins, to obtain immune sera of laboratory animals, and also as a component of test systems for the detection of specific antibodies with ELISA and immunoblotting.
Reference24 articles.
1. Virus Taxonomy: 2019 Release. EC 51, Berlin, Germany, July 2019. International website [Internet]. Available from: https://talk.ictvonline.org/taxonomy/ (10.06.2020).
2. Masters, P.S. The molecular biology of coronaviruses / P.S. Masters // Adv. Virus. Res. – 2006. – Vol. 66. – P. 193- 292. – doi: 10.1016/S0065-3527(06)66005-3.
3. Accessory proteins of SARS-CoV and other coronaviruses / D.X. Liu, T.S. Fung, K.K. Chong, et al. // Antiviral Res. – 2014. – Vol. 109. – P. 97-109. – doi: 10.1016/j.antiviral.2014.06.013.
4. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status / Y.R. Guo, Q.D. Cao, Z.S. Hong, et al. // Mil. Med. Res. – 2020. – Vol. 7. – N. 1. – P. 11. – doi: 10.1186/s40779-020-00240-0.
5. WHO Director-General’s opening remarks at the Mission briefing on COVID-19 – 12 March 2020. International website [Internet]. URL: https://www.who.int/ru/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19---12-march-2020 (available 19.06.2020).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献